Related Experiment Videos

Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells

V Ehrlich1, F Darroudi, M Uhl

  • 1Institute of Cancer Research, University of Vienna, Borschkegasse 8a, A-1090, Vienna, Austria. veronikaehrlich@hotmail.com

Insights

Ochratoxin A (OTA), a common mycotoxin, demonstrated clastogenic effects in human liver cells, indicating potential genotoxic risks in humans. Further research supports its role in hepatic tissue damage.

Area of Science:

  • Toxicology
  • Genetics
  • Food Safety

Background:

  • Ochratoxin A (OTA) is a prevalent mycotoxin found globally in various food commodities.
  • Accumulating evidence suggests a potential carcinogenic link between OTA exposure and human health.

Purpose of the Study:

  • To investigate the genotoxic potential of Ochratoxin A in human-derived cells.
  • To assess OTA's clastogenic and mutagenic effects using established in vitro assays.

Main Methods:

  • Micronucleus (MN) and single-cell gel electrophoresis (SCGE) assays were performed on human hepatoma (HepG2) cells.
  • Salmonella microsome assays (Ames test) with HepG2-derived S9 mix were conducted to evaluate mutagenicity.

Main Results:

  • OTA induced significant dose-dependent clastogenic effects in HepG2 cells at concentrations of 5 microg/ml and higher.
  • No mutagenic activity (His(+) revertants) was observed in Salmonella strains TA98 and TA100 under identical exposure conditions.

Conclusions:

  • Ochratoxin A exhibits clastogenic activity in human-derived liver cells.
  • These findings suggest that OTA may pose a genotoxic risk to human hepatic tissues.

Related Concept Videos